GDRX GoodRx Holdings, Inc.

2.920USD-3.31%Mkt Cap: 996.14M USDP/E: 58.40

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap996.14M USD
Enterprise Value1.27B USD
Revenue (TTM)785.23M USD
Gross Profit739.26M USD
Net Income (TTM)30.44M USD
Revenue/Share2.29 USD
Last Price2.920 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees697
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)58.40
P/E (Forward)8.29
PEG—
EV/EBITDA11.70
EV/Revenue1.62
P/S1.27
P/B1.53
EPS (TTM)0.05 USD
EPS (Forward)0.35 USD
52W Range
1.77054% of range3.885
52W High3.885 USD
52W Low1.770 USD
Profitability
Gross Margin92.77%
Oper. Margin11.36%
EBITDA Margin13.85%
Profit Margin3.82%
ROE4.94%
ROA2.17%
ROIC5.25%
ROCE7.56%
Growth
Revenue Growth-1.30%
Earnings Growth-44.50%
Cash Flow & Leverage
Operating CF167.90M USD
CapEx (TTM)74.02M USD
FCF Margin14.33%
FCF Yield11.29%
Net Debt242.84M USD
Net Debt/EBITDA2.23
Net Debt/FCF2.16
Balance Sheet
Debt/Equity0.88
Current Ratio1.38
Quick Ratio0.42
Book Value/Sh1.90 USD
Cash/Share0.87 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.950 USD
Upside (mean)+35.3%
Target Range2.650 USD – 5.000 USD
2.650+35.3% to mean5.000
# Analysts12
Ownership
Shares Out.107.18M
Float93.47M
Insiders12.98%
Institutions63.52%
Short Interest
Short Ratio3.5d
Short % Float3.73%
Short % Out.1.05%
Shares Short3.57M
Short (prev mo.)4.16M
Technical
SMA 503.444 (-15.2%)
SMA 2002.890 (+1.0%)
Beta1.66
S&P 52W Chg12.00%
Avg Vol (30d)1.18M
Avg Vol (10d)1.02M
Technical Indicators
RSI (14)31.2
MACD-0.0703
MACD Signal0.0004
MACD Hist.-0.0707
BB Upper3.854 USD
BB Middle3.474 USD
BB Lower3.095 USD
BB Width21.82%
ATR (14)0.1740 USD
Vol Ratio (20d)1.64x

About GoodRx Holdings (NASDAQ: GDRX)

›

GoodRx Holdings (NASDAQ: GDRX) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 697 employees.

The shares were at 2.920 USD on 20 November 2026, down 6.1% over 52 weeks. Its 52-week range is 1.770 USD to 3.885 USD: the price is 24.8% below the high and 65.0% above the low.

At a market capitalisation of 996.14M USD, it trades at 58.4 times trailing earnings and 8.3 times forward earnings. The median trailing P/E of its 15 largest Health Information Services peers is 39.9, a premium of 46% for GDRX.

GoodRx Holdings reports return on equity of 4.9%, an operating margin of 11.4% and revenue down 1.3% year over year.

Its debt exceeds its cash by 242.84M USD, a debt-to-equity ratio of 0.88. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Hold; their mean price target of 3.950 USD is 35.3% above the current price. The next earnings report is expected on 23 November 2026.